When memory fades and caregiving becomes a daily reality, how do we hold onto hope? In this episode of the Russo Edge Podcast, novelist and mental health advocate Muffy Walker shares how her experiences helped inspire her debut work of fiction, Memory Weavers.

Set in the late 1990s and early 2000s, the novel follows two women navigating friendship, trauma, and early-onset memory loss. Drawing from her background as a psychiatric nurse and advocate, Muffy talks about why she chose fiction to explore these emotional realities, how stigma impacts families, and why telling these stories matters. This heartfelt conversation offers resilience, compassion, and inspiration for anyone touched by memory loss, trauma, or mental health struggles.

Sara Jane Demy, CEO and Founder of Demy-Colton, has spent more than two decades helping biotech CEOs get into the right rooms—and build the relationships that move their companies forward.

In this episode of The Russo Edge Podcast, Sara joins host Solomon Wilcots for a candid conversation about what it takes to lead in today’s capital-constrained biotech environment. She shares why preparation—not just presence—is the key to investor meetings, and what biotech CEOs often get wrong about outreach. Whether you’re a first-time founder or a veteran CEO, this episode offers practical guidance, honest insights, and a look at how the playbook for biotech leadership is being written in real time.

Shaun O’Hara, Ed McCaffrey, and Alex Smith join host Solomon Wilcots from Radio Row for an in-depth conversation on the evolving role of sports medicine in professional football. These NFL veterans share their personal experiences with injuries, recovery, and the medical advancements that helped extend their careers.

Alex Smith shares his journey back from a career-threatening leg injury, Ed McCaffrey reflects on the long-term impact of the game and post-retirement health, and Shaun O’Hara discusses how today’s athletes are better equipped for injury prevention and recovery. As former pros—Smith, a 16-season quarterback, McCaffrey, a championship-winning wide receiver, and O’Hara, a New York Giants offensive lineman—they explore advancements in sports medicine, from orthopedic treatments to the role of nutrition, sleep, and cutting-edge rehab techniques.

Dr. Shiran Zimri, Vice President of R&D at NeuroSense Therapeutics, joins the Russo Edge Podcast and shares her journey as a scientist tackling neurodegenerative diseases like ALS.

In this episode, Dr. Zimri explains how NeuroSense’s innovative combination therapy, Prime C, could reshape ALS treatment by addressing multiple pathways involved in the disease. She provides a behind-the-scenes look at the company’s recent clinical trial successes and the deeply personal story that inspired the founding of NeuroSense.

Dr. Paul Wotton, Executive Director of the Rice Biotech Launchpad and Managing Partner of RBL LLC, joins host Solomon Wilcots on the Russo Edge Podcast. In this episode, Dr. Wotton shares how his leadership is transforming groundbreaking research into clinical applications.

Discover the unique advantages of Houston's thriving biotech ecosystem, the challenges of translating research into treatments, and the strategies biotech CEOs can use to effectively communicate and secure funding. Tune in for a compelling discussion filled with actionable insights and innovative solutions for life science leaders.

Kevin Caldwell, CEO and co-founder of Ossium Health, joins the Russo Edge Podcast to share the groundbreaking work his company is doing to revolutionize bone marrow transplants.

Learn how Ossium Health is leveraging innovation to store life-saving bone marrow from deceased organ donors and improve outcomes for patients with serious blood cancers. With host Solomon Wilcots, this episode covers the challenges of scaling biotech solutions and the transformative potential of modern medicine.

Gaylene Xanthopoulos, CEO and founder of The Leadership Edge, joins the Russo Edge Podcast to share her expertise on leading life science companies through growth, innovation, and investor engagement.

As an advisor to biotech CEOs and board members, Gaylene delves into the unique challenges life science leaders face today, from building effective teams to establishing strategic clarity and fostering resilience. She also offers advice on preparing for high-stakes events like the JPMorgan Healthcare Conference and the art of communicating effectively with investors.

Join Graig Suvannavejh, veteran biotech and biopharmaceutical analyst at Mizuho Securities, as he sits down with our host Solomon Wilcots, Sports-Health Alliance Team Leader at Russo Partners.

In this episode, Graig discusses the evolving biotech landscape, upcoming market catalysts, and the key therapeutic areas poised for growth. We also dive into best practices for companies looking to strengthen relationships with analysts and investors.